ZJYL (zhjmedical.com) Market Value to Book Value Ratio

zhjmedical.com - graphic logo of issuer ZJYL

Jin Medical International (ZJYL) bases its operations on the demand for rehabilitation equipment and wheelchairs, while controlling costs and the reach of global distribution networks. This daily price chart confirms the success of Jin Medical International's strategy to expand exports and product sales within the PRC. Developments in robotics and lightweight electric drives are refreshing the product line, and the key metric reaches 0.60.

zhjmedical.com (ZJYL) Market Capitalization to Net Assets: for the period 02/21/2024 - 10/31/2026
Flagship merchandise of Jin Medical International

This ratio determines the extent to which the market overvalues the company's assets. By analyzing the relationship between the company's current market price and its net book assets, an investor can identify the premium over the cost of equity. The metric is calculated by dividing the market capitalization by the difference between total assets and liabilities. For Jin Medical International (ZJYL), this indicator reflects the monetization of social trust in the quality of its rehabilitation equipment. High values confirm the capitalization of the product's reliability and ergonomics.

Competitor analysis

Boston Scientific (BSX) - Market Value to Book Value Ratio|EW (edwards.com) - Market Value to Book Value Ratio|Market Value to Book Value Ratio ResMed|Insulet Corp (PODD) - Market Capitalization to Book Value|Market Value to Book Value Ratio Zimmer Biomet Holdings, Inc. (ZBH)|COO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio ALGN (Align Technology, Inc.)|globusmedical.com (GMED) - Market-to-Book Ratio|TransMedics Group - Market Capitalization to Book Value Ratio|Alphatec Holdings (ATEC) - Market Cap to Net Assets Ratio|AORT: Market Capitalization to Book Value Ratio|ENOV - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio establishmentlabs.com|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRMD (IRADIMED Corp)|Market Capitalization to Book Value Ratio EMBC (Embecta Inc.)|Market Capitalization to Book Value Tandem Corp (TNDM)|AXGN: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets SIBN|OFIX: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Bioventus Inc (BVS)|KIDS (OrthoPediatrics Corp) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio TMCI (Treace Corp)|Market Cap to Net Assets Ratio SRTA (Strata Critical Medical Inc)|CARL (carlsmed.com) - Market Value to Book Value|Market Value to Book Value Ratio RxSight RXST|CLPT - Market Cap to Net Assets Ratio|Stereotaxis Corp - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Neuronetics, Inc|SGHT: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio OBIO|ANIK (Anika Therapeutics Inc.) - Market Capitalization to Book Value Ratio|InspireMD Inc (NSPR) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio VANI|Market Cap to Net Assets Ratio xtantmedical.com XTNT|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Market Capitalization to Book Value Ratio Modular Medical Inc MODD|MYO - Market Value to Book Value Ratio|COCH: Market Value to Book Value Ratio|VVOS (Vivos Therapeutics, Inc) - Market Cap to Net Assets Ratio|enVVeno Corp - Market Value to Book Value|SINT (Sintx Technologies Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio tenonmed.com TNON|Market Value to Book Value Ratio Lifeward (LFWD)|autonomix.com (AMIX) - Market Value to Equity Ratio|INVO Bioscience, Inc. - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Axonics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value biolase.com BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Capitalization to Net Assets FNA (Paragon 28)|Market Value to Book Value Ratio INVO Bioscience Inc.